AI to Accelerate Diagnosis of Retinal Disorders

New-Stem-Cell-Treatment-Can-Cure-Macular-Degeneration

Artificial Intelligence-based neural network reviews more than 200,000 eye scans with optical coherence tomography to create two- and three-dimensional representations of retinal tissue

The findings of the study was published on February 22, 2018 in journal of Cell. Researchers from Shiley Eye Institute at UC San Diego Health and University of California San Diego School of Medicine, with colleagues in China, Germany and Texas developed new software for detection of retinal disorders for speeding up diagnosis and treatment. The study was focused macular degeneration and diabetic macular edema, which are two major causes of blindness. This machine learning technique was found to be as accurate as trained ophthalmologist. It generates most referred treatment to the patients within 30 seconds with 95% accuracy.

Conventional approaches to diagnose retinal disorders are laborious and expensive. They require millions of images to program AI system. In this study, researchers used AI-based convolutional neural network, which was capable of reviewing more than 200,000 eye scans with optical coherence tomography. It is a noninvasive technology, which transmits light to retina to creating two- and three-dimensional representations of tissue.

“Artificial intelligence (AI) has huge potential to revolutionize disease diagnosis and management by doing analyses and classifications involving immense amounts of data that are difficult for human experts—and doing them rapidly,” said senior author Kang Zhang, MD, PhD, professor of ophthalmology at Shiley Eye Institute and founding director of the Institute for Genomic Medicine at UC San Diego School of Medicine.

Speed and accuracy are the most important steps in medical diagnoses and treatment. Simple and relatively inexpensive AI-based tool could help various medical resources and specialists in efficient treatment of disorders. Furthermore, AI technology can also differentiate between benign and malignant lesions in just one scan. The scientists are sharing data their data through open-source so that other research organizations can develop potential applications.

You may be interested

Smart Nanotechnology Enlivens Wooden Ships and Artifacts
Business
Business

Smart Nanotechnology Enlivens Wooden Ships and Artifacts

Mohit Joshi - January 28, 2019

Scientists developed an innovative approach using ‘smart’ nanocomposites to conserve 16th-century British warship, the Mary Rose, and its artifacts. Shipwrecks are preserved in sediments under cold water,…

Researchers Discovered New Properties of Ferroelectric Crystal
Business
Business

Researchers Discovered New Properties of Ferroelectric Crystal

Mohit Joshi - January 25, 2019

Researchers discovered new properties of ferroelectric crystal, according to a study published on July 10, 2018. This study was conducted by a team of researchers from China.…

Researchers Develop Novel Antibody to Knockdown of Protein in Vertebrates
Healthcare
Healthcare

Researchers Develop Novel Antibody to Knockdown of Protein in Vertebrates

Mohit Joshi - January 24, 2019

Researchers from Technische Universität Dresden developed a synthetic antibody that improves functional analysis of proteins. A research led by Dr. Jörg Mansfeld of the Biotechnology Center of…

Most from this category